TrinityPoint Wealth »

Halozyme Therapeutics shares owned by TrinityPoint Wealth

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by TrinityPoint Wealth from 13F filings

Historical chart of TrinityPoint Wealth investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by TrinityPoint Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by TrinityPoint Wealth

Quarter filed Position value Share count Share price at filing
2024-09-30 $214k 3.7k 57.24

More positions owned by TrinityPoint Wealth

Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
NVIDIA Corporation (NVDA)
Invesco Exchange Traded Fd T S&p 500 Garp Etf (SPGP)
Abbvie (ABBV)
Alphabet Cap Stk Cl A (GOOGL)
Select Sector Spdr Tr Technology (XLK)
Honeywell International (HON)
JPMorgan Chase & Co. (JPM)
Ishares Tr Sp Smcp600vl Etf (IJS)
Select Sector Spdr Tr Financial (XLF)

View all positions for TrinityPoint Wealth

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Snyder Capital Management
Bank of America Corporation
Alliancebernstein
Geode Capital Management
Macquarie Group
Jpmorgan Chase & Co
Invesco
Congress Asset Management
Dimensional Fund Advisors
Goldman Sachs Group
Northern Trust
Charles Schwab Investment Management

View all funds holding Halozyme Therapeutics